Recombinant CA9 anticorps (full length)
Aperçu rapide pour Recombinant CA9 anticorps (full length) (ABIN7877771)
Antigène
Voir toutes CA9 AnticorpsType d'anticorp
Reactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Épitope
- full length
-
Fonction
- Recombinant Carbonic Anhydrase 9 Antibody / CA9
-
Purification
- Protein A/G affinity
-
Immunogène
- Recombinant full-length human CA9 protein was used as the immunogen for the recombinant Carbonic Anhydrase 9 antibody.
-
Isotype
- IgG2b, kappa
-
-
-
-
Indications d'application
- Optimal dilution of the recombinant Carbonic Anhydrase 9 antibody should be determined by the researcher.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.2 mg/mL
-
Buffer
- 0.2 mg/mL in 1X PBS with 0.1 mg/mL BSA (US sourced), 0.05 % sodium azide
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Aliquot the recombinant Carbonic Anhydrase 9 antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
-
-
- CA9 (Carbonic Anhydrase IX (CA9))
-
Autre désignation
- Carbonic Anhydrase 9
-
Sujet
- In normal kidney, CA9 is localized along the brush border of the pars convoluta and pars recta segments of the proximal tubule, as well as focally along the luminal surface of Bowman's capsule adjoining the outgoing proximal tubule. Reportedly, CA9 is expressed by 93 % of primary and 84 % of metastatic renal cell carcinomas. This MAb may be useful in the investigations of carcinomas of proximal nephrogenic differentiation especially those showing tubular differentiation.
-
UniProt
- Q16790
Antigène
-